|
Real-time Estimate
Cboe BZX
21:04:13 09/02/2026 GMT
|
5-day change
|
1st Jan Change
|
|
18.62 USD
|
+5.05%
|
|
-8.11%
|
-21.94%
|
|
02-05 |
Bernstein Initiates Coverage on Coupang With Underperform Rating, $17 Price Target
|
MT
| |
01-16 |
Deutsche Bank Upgrades Coupang to Buy From Hold, Adjusts Price Target to $25 From $29
|
MT
| |
01-13 |
Coupang Shares Fall After Nomura Downgrade
|
MT
| |
01-13 |
Nomura Downgrades Coupang to Neutral From Buy, Cuts Price Target to $22 From $30
|
MT
| |
01-13 |
Nomura Downgrades Coupang to Neutral From Buy, Cuts Price Target to $22 From $30
|
MT
| |
12-17 |
Nomura Adjusts Coupang Price Target to $30 From $38, Maintains Buy Rating
|
MT
| |
18/09/25 |
Arete Initiates Coverage on Coupang With Buy Rating, $40 Price Target
|
MT
| |
11/09/25 |
On the stock market, inflation pushes Oracle off the front page.
|  | |
20/08/25 |
Coupang's Growing Taiwan Business to Drive Long-term Growth, Morgan Stanley Says
|
MT
| |
20/08/25 |
Morgan Stanley Lifts Price Target on Coupang to $35 From $32, Keeps Overweight Rating
|
MT
| |
06/08/25 |
Deutsche Bank Downgrades Coupang to Hold From Buy, Price Target is $27
|
MT
| |
05/08/25 |
Coupang Q2 revenue up 16%, beats analyst expectations
|
RE
| |
27/05/25 |
Coupang to Meet 2025 Growth Targets as Market Share Gains Continue, Morgan Stanley Says
|
MT
| |
27/05/25 |
Morgan Stanley Raises Price Target on Coupang to $32 From $27, Keeps Overweight Rating
|
MT
| |
26/02/25 |
Deutsche Bank Upgrades Coupang to Buy From Hold
|
MT
| |
07/10/24 |
Bernstein Upgrades Coupang to Outperform From Underperform, Price Target is $30
|
MT
| |
16/05/24 |
UBS Upgrades Coupang to Buy From Neutral
|
MT
| |
09/05/24 |
Barclays Adjusts Price Target on Coupang to $32 From $25, Maintains Overweight Rating
|
MT
| |
08/05/24 |
Mizuho Adjusts Coupang's Price Target to $23 From $20, Keeps Neutral Rating
|
MT
| |
16/04/24 |
Nomura Raises Price Target on Coupang to $26 From $21 on Increased Membership Fee, Keeps Buy Rating
|
MT
| |
15/04/24 |
Coupang Remains Top Pick Following Membership Fee Increase, Morgan Stanley Says
|
MT
| |
15/04/24 |
Citigroup Upgrades Coupang to Buy From Neutral, Adjusts Price Target to $26 From $19
|
MT
| |
15/04/24 |
Morgan Stanley Lifts Price Target on Coupang to $26 From $24 to Reflect WOW Membership Price Increase; Overweight Kept
|
MT
| |
20/03/24 |
Coupang Insider Sold Shares Worth $2,538,210, According to a Recent SEC Filing
|
MT
| |
29/02/24 |
Barclays Adjusts Price Target on Coupang to $25 From $24, Maintains Overweight Rating
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
|